Latest Period
Q2 2026
Security Snapshot
ENvue Medical, Inc. - Common Stock (FEED) Institutional Ownership
CUSIP: 63008J884
13F Institutional Holders and Ownership History from Q3 2025 to Q2 2026
Institutions Reporting
13
Shares (Excl. Options)
290,971
Price
$0.52
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- FEED on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 290,971
- Total 13F value
- $149,249
- Portfolio coverage rank
- 0%
- Share change
- +211,508
- Value change
- +$36,368
- Number of holders
- 13
- Shares outstanding
- 1,089,465
- SEC-reported price per share
- $0.41
- Insider filing price
- $0.41
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- FEED - ENvue Medical, Inc. - Common Stock is tracked under CUSIP 63008J884.
- 13 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 13 to 13 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $179,220 to $149,249.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 13 institutions filings for Q2 2026.
Security key
63008J884
Latest holder period
Q2 2026
13F holders
13
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
FEED full holder history
ENvue Medical, Inc. SEC filings
ENvue Medical, Inc. company facts
ENvue Medical, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 63008J884:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
FEED
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 0% | -98% | $39.76 | -$665,188 | 14 | -100% | BANK OF AMERICA CORP /DE/ | 27 Feb 2026 |
As of 30 Jun 2026, 13 institutional investors reported holding 290,971 shares of ENvue Medical, Inc. - Common Stock (FEED). This represents 27% of the company’s total 1,089,465 outstanding shares.
13F concentration
Top 19 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
27%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| HRT FINANCIAL LP | 11% | 115,579 | 0% | $59,000 | |
| Virtu Financial LLC | 8.7% | 95,296 | 0% | $49,000 | |
| JANE STREET GROUP, LLC | 3.5% | 37,635 | 0% | $19,382 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.4% | 15,466 | -31% | 0% | $7,964 |
| TWO SIGMA SECURITIES, LLC | 0.94% | 10,279 | 0% | $5,294 | |
| OSAIC HOLDINGS, INC. | 0.92% | 10,000 | 0% | 0% | $5,150 |
| Tower Research Capital LLC (TRC) | 0.44% | 4,781 | +70% | 0% | $2,462 |
| Global Retirement Partners, LLC | 0.15% | 1,600 | 0% | $824 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.02% | 189 | 0% | 0% | $97 |
| VANGUARD FIDUCIARY TRUST CO | 0.01% | 85 | 0% | 0% | $44 |
| WELLS FARGO & COMPANY/MN | 0% | 45 | 0% | 0% | $23 |
| SBI Securities Co., Ltd. | 0% | 15 | 0% | 0% | $8 |
| Caitong International Asset Management Co., Ltd | 0% | 1 | 0% | $1 | |
| FMR LLC | 0% | 0 | -100% | $0 | |
| Schonfeld Strategic Advisors LLC | 0% | 0 | -100% | $0 | |
| Poehling Capital Management, INC. | 0% | 0 | -100% | $0 | |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 0% | 0 | -100% | $0 | |
| UBS Group AG | 0% | 0 | -100% | $0 | |
| MORGAN STANLEY | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Latest
Q2 2026
Rows shown
1-4 of 4